Genetic Signatures Limited
Research Genetic Signatures Limited (GSS.AX) on Bullrun: market cap AUD 18.17M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGSS.AX
- ExchangeAU
- CountryAustralia
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyAUD
- Market capAUD 18.17M
- Financial periodFY2026
- RevenueAUD 14.45M
- Revenue growth-9.1%
- Net income-AUD 14.01M
- Free cash flow-AUD 8.82M
- Gross margin34.5%
Valuation Snapshot
latest market cap is AUD 18.17M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | AUD 14.45M | -AUD 14.01M | -AUD 8.82M | 34.5% | n/a | AUD 9.07M | AUD 310.00K | AUD 35.72M |
| FY2025 | AUD 15.90M | -AUD 20.10M | -AUD 13.19M | 48.9% | -0.09 | AUD 7.47M | AUD 791.00K | AUD 50.09M |
| FY2024 | AUD 9.77M | -AUD 17.86M | -AUD 14.91M | 44.1% | -0.11 | AUD 36.25M | AUD 1.22M | AUD 61.10M |
| FY2023 | AUD 21.36M | -AUD 14.05M | -AUD 20.55M | 62.6% | -0.1 | AUD 16.35M | n/a | AUD 42.91M |
| FY2022 | n/a | n/a | n/a | n/a | 0.02 | n/a | AUD 34.00K | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-17 | AUD 18.17M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 AUD.
About Genetic Signatures Limited
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Genetic Signatures Limited's market cap?
Genetic Signatures Limited's market capitalization is AUD 18.17M.
What does Genetic Signatures Limited do?
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. The company offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, and Rubella detection kits under the EasyScreen name. Genetic Signatures Limited was incorporated in 2001 and is headquartered in Newtown, Australia.